Low/Intermediate PCa Video Chat, January 26, 2026
Low/Intermediate PCa Video Chat, January 26, 2026
AnCan is grateful to the following sponsors for making this recording possible: Novartis, Johnson and Johnson, Telix, Blue Earth Diagnostics, and Foundation Medicine.
WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.
- Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
- Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern https://ancan.org/veterans/
- You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/
- Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/
Editor’s Pick: Dangers of high PSA going untreated. (bj)
Topics Discussed
Dangers of high PSA going untreated; strategies for getting past treatment decision anxiety and worries about side effects; getting a second opinion with VA Healthcare and accessing community care; aquablation therapy and steady PSA; cribriform concerns; health care team more important than the technology; focal therapy—understanding if you are a good candidate; research is good, but you can overdo it; using MSKCC nomogram to determine how likely you will need treatment after surgery; advantages of MR-Linac for radiation treatment; incorporating multiple comorbidities into your treatment decision; concerns with MR-Linac with urinary flow issues; Heatwave study; Androgen Deprivation Therapy (ADT) therapy discussion to include monotherapy and LRHR (luteinizing hormone-releasing hormone receptor); benefits of participating in trials.
Chat